跳至主要内容
临床试验/NCT02277626
NCT02277626已完成4 期

Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and Vest Therapy in

Stanford University0 个研究点目标入组 15 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
15
主要终点
Wet Sputum Weight

研究概览

简要总结

It is the goal of the proposed study to compare the efficacy, as assessed primarily by sputum weight, of these two different devices (the Electroflo 500 and VEST therapy) for airway clearance (AC) in CF patients with mild to moderate lung disease, who have stable lung health and perform AC at home as part of their routine therapeutic regimen.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of CF established by standard criteria (sweat chloride > 60 mmol/L and/or two alleles affected by gene mutations know to be associated with CF).
  • Age older than 12 years.
  • Known to consistently produce sputum.
  • Currently on a home therapeutic regimen that includes some form of AC performed at least 2 times daily.
  • FVC and FEV1 > 40%-predicted, and with stable lung function (no greater than a 10% variation in lung function parameters over the preceding 3 months).

排除标准

  • Hospitalization for CF pulmonary complications in the 2 months preceding enrollment.
  • Hemoptysis > 60 cc in a single episode in the 4 weeks preceding enrollment.
  • Chronic chest pain.
  • Participation in another interventional clinical trial in the previous 30 days. -

结局指标

主要结局

Wet Sputum Weight

时间窗: End of study visit per intervention

Sputum was collected in pre-measured cups in a blinded fashion

Pulmonary Function Measured as a Percent Predicted BEFORE Therapy With Either ElectroFlo 5000 / VEST.

时间窗: End of study visit per intervention

Comparison of pulmonary function by doing spirometry testing on study patients during their Day 1 \& Day 2 therapy sessions. Will also compare the results based on the therapies they receive.

Pulmonary Function Measured as a Percent Predicted AFTER Therapy With Either ElectroFlo 5000 / Vest.

时间窗: End of study visit per intervention

Comparison of pulmonary function by doing spirometry testing on study patients during their Day 1 \& Day 2 therapy sessions. Will also compare the results based on the therapies they receive.

Comfort Level After Receiving Therapy With Either ElectroFlo 5000 / Vest

时间窗: End of study visit per intervention

Comfort assessed on a scale of 1-10 by patients after therapy after each visit (1 being most comfortable, 10 being most un-comfortable)

次要结局

  • Dry Sputum Weight(End of study visit per intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Milla

Principal Investigator

Stanford University

相似试验